Ho Yao - Net Worth and Insider Trading
Ho Yao Net Worth
The estimated net worth of Ho Yao is at least $174 Million dollars as of 2024-06-22. Ho Yao is the of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 12,008,757 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $174 Million. Details can be seen in Ho Yao's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ho Yao has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).
Transaction Summary of Ho Yao
Ho Yao Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ho Yao owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .
Click here to see the complete history of Ho Yao’s form 4 insider trades.
Insider Ownership Summary of Ho Yao
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 |
Ho Yao Latest Holdings Summary
Ho Yao currently owns a total of 1 stock. Ho Yao owns 12,008,757 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $174 Million.
Latest Holdings of Ho Yao
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 12,008,757 | 14.48 | 173,886,801 |
Holding Weightings of Ho Yao
Ho Yao Form 4 Trading Tracker
According to the SEC Form 4 filings, Ho Yao has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 0 shares on September 5, 2023, which brought Ho Yao around $0.
Insider Trading History of Ho Yao
- 1
Ho Yao Trading Performance
Ho Yao Ownership Network
Ho Yao Owned Company Details
What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?
Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?
Ho Yao is the of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include CHENG YIQUAN , 2102 Investment manager LAV Asset Management (Hong Kong) Limited , and 2201 Interest of corporation controlled by you Shi Yi .
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary
Over the past 18 months, Ho Yao made no insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541). Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 0 shares made by Halo Biomedical Investment I Limited , a net sale of 0 shares made by LAV GP V, L.P. , and a net sale of 0 shares made by Halo Biomedical LP .
In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions
Ho Yao Mailing Address
Above is the net worth, insider trading, and ownership report for Ho Yao. Currently GuruFocus does not have mailing address information for Ho Yao.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
